589
Participants
Start Date
September 30, 2012
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
Imiquimod Cream, 3.75%
Zyclara®
Vehicle of Test Product
Philadelphia Institute of Dermatology, Fort Washington
MedaPhase, Inc., Newnan
Park Avenue Dermatology, PA, Orange Park
Leavitt Medical Associates of Florida dba Ameriderm Research, Ormond Beach
Jacksonville Center for Clinical Research, Jacksonville
International Dermatology Research, Inc., Miami
Tory Sullivan, M.D., P.A., North Miami Beach
Visions Clinical Research, Boynton Beach
Tampa Bay Medical Research, Clearwater
Radiant Research, Inc., Pinellas Park
Dermatology Specialists Research LLC, Louisville
Radiant Research, Inc., Cincinnati
The Indiana Clinical Trials Center, Plainfield
Altman Dermatology Associates, Arlington Heights
Research Across America, Dallas
Longmont Clinic, PC, Longmont
Radiant Research, Inc., Tucson
Dermatology Research Associates, Los Angeles
Encino Research Center, Encino
Skin Surgery Medical Group, Inc., San Diego
Northern California Research, Sacramento
Oregon Medical Research Center, PC, Portland
Omega Medical Research, Warwick
Teva Pharmaceuticals USA
INDUSTRY